Pushing the Performance Boundaries of Highly Energetic Bis(1,2,4-triazoles) through Merging Dual Strategies of C-Azo Bridging and N -Nitramino Functionalization
Organic Letters · 12.09.2025 · 27 (36) · 10043-10048
DOI: 10.1021/acs.orglett.5c03115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 28.08.2025. Verfasst von Yangyang Long und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science & Engineering, Beijing Institute of Technology, Beijing 100081, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Materials Science & Engineering, Beijing Institute of Technology, Beijing 100081, China.
- Beijing Institute of Technology, Chongqing Innovation Center, Chongqing 401120, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Long, Y., Su, D., Zhang, H., Xia, Y., Lai, Q., Yin, P., & Pang, S. (2025). Pushing the Performance Boundaries of Highly Energetic Bis(1,2,4-triazoles) through Merging Dual Strategies of C-Azo Bridging and N -Nitramino Functionalization. Organic Letters, 27(36), 10043-10048. https://doi.org/10.1021/acs.orglett.5c03115
Vancouver
Long Y, Su D, Zhang H, Xia Y, Lai Q, Yin P, et al. Pushing the Performance Boundaries of Highly Energetic Bis(1,2,4-triazoles) through Merging Dual Strategies of C-Azo Bridging and N -Nitramino Functionalization. Organic Letters. 2025;27(36):10043-10048. doi:10.1021/acs.orglett.5c03115
BibTeX
@article{Long2025,
author = {Long, Yangyang and Su, Dongshuai and Zhang, Hui and Xia, Yingqi and Lai, Qi and Yin, Ping and Pang, Siping},
title = {Pushing the Performance Boundaries of Highly Energetic Bis(1,2,4-triazoles) through Merging Dual Strategies of C-Azo Bridging and N -Nitramino Functionalization},
journal = {Organic Letters},
year = {2025},
volume = {27},
number = {36},
pages = {10043--10048},
doi = {10.1021/acs.orglett.5c03115}
}
EUVIMED